simvastatin has been researched along with Cavernous Angioma, Central Nervous System in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caprihan, A; Hart, BL; Kim, H; Mabray, MC; McCulloch, CE; Morrison, L; Nelson, J; Zafar, A | 1 |
| Eisa-Beygi, S | 1 |
| Felbor, U; Geisen, U; Heinz, J; Meckel, S; Reinhard, M; Schuchardt, F; Sure, U | 1 |
| Austin, C; Awad, IA; Cao, Y; Gallione, C; Girard, R; Liao, JK; Lightle, R; Marchuk, DA; McDonald, DA; Moore, T; Pytel, P; Rorrer, A; Shenkar, R; Shi, C; Wu, M; Zeineddine, HA; Zhang, L | 1 |
| Couldwell, WT; Krisht, KM; Niazi, T; Whitehead, KJ | 1 |
1 review(s) available for simvastatin and Cavernous Angioma, Central Nervous System
| Article | Year |
|---|---|
The pathogenetic features of cerebral cavernous malformations: a comprehensive review with therapeutic implications.
Topics: Animals; Apoptosis Regulatory Proteins; Carrier Proteins; Disease Models, Animal; Hemangioma, Cavernous, Central Nervous System; Humans; KRIT1 Protein; Membrane Proteins; Mice; Microtubule-Associated Proteins; Proto-Oncogene Proteins; Signal Transduction; Simvastatin | 2010 |
1 trial(s) available for simvastatin and Cavernous Angioma, Central Nervous System
| Article | Year |
|---|---|
Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial.
Topics: Adult; Capillary Permeability; Female; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Pilot Projects; Prospective Studies; Simvastatin; Treatment Outcome | 2020 |
3 other study(ies) available for simvastatin and Cavernous Angioma, Central Nervous System
| Article | Year |
|---|---|
Simvastatin and cerebral cavernous malformations (Re: Reinhard et al., 2016).
Topics: Anticholesteremic Agents; Hemangioma, Cavernous, Central Nervous System; Humans; Male; Simvastatin; Young Adult | 2016 |
Authors' response to the letter by Dr. Eisa-Beygi.
Topics: Hemangioma, Cavernous, Central Nervous System; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2016 |
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Brain Neoplasms; Disease Models, Animal; Female; Hemangioma, Cavernous, Central Nervous System; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Transgenic; Protein Kinase Inhibitors; rho-Associated Kinases; Simvastatin | 2017 |